A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
Incidence of potential adverse events during hospital-based ketogenic diet initiation among children with drug-resistant epilepsy
Comprehensive Wellness Support Individuals seeking a broader peptide program instead of relying on a single peptide therapy
Liver Fat Reduction: Where Glucagon Agonists Excel The survodutide vs retatrutide vs tirzepatide comparison reveals a particularly important distinction when it comes to metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD)
MO, USA) was dissolved in 100% ethanol and diluted in saline solution to the required concentration
A total of 35 and 100 nl AAV-hSyn-Cre-p2a-dTomato (Addgene, 107738-AAV9), AAV-hEF1-dlox-DTA (AAV-DTA as per ref